Allgens Medical Technology CO., LTD. (688613.SS)
CNY 15.44
(-3.5%)
CNY 15.44
(-3.5%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -107.83 Million CNY | 45.62% |
| 2022 | -198.28 Million CNY | 40.04% |
| 2021 | -330.67 Million CNY | -1166.41% |
| 2020 | 31 Million CNY | 207.29% |
| 2019 | -28.9 Million CNY | 66.48% |
| 2018 | -86.22 Million CNY | -561.64% |
| 2017 | -13.03 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -113 Million CNY | 12.53% |
| 2024 Q2 | -129.18 Million CNY | -2.15% |
| 2024 Q1 | -126.47 Million CNY | -17.28% |
| 2023 Q4 | -107.83 Million CNY | 8.65% |
| 2023 FY | -107.83 Million CNY | 45.62% |
| 2023 Q3 | -118.04 Million CNY | 20.4% |
| 2023 Q2 | -148.29 Million CNY | 0.48% |
| 2023 Q1 | -149.01 Million CNY | 24.85% |
| 2022 Q3 | -217.89 Million CNY | 20.01% |
| 2022 Q2 | -272.38 Million CNY | 4.86% |
| 2022 Q1 | -286.29 Million CNY | 13.42% |
| 2022 FY | -198.28 Million CNY | 40.04% |
| 2022 Q4 | -198.28 Million CNY | 9.0% |
| 2021 Q1 | 35.92 Million CNY | 15.86% |
| 2021 FY | -330.67 Million CNY | -1166.41% |
| 2021 Q3 | -385.04 Million CNY | 13.86% |
| 2021 Q4 | -330.67 Million CNY | 14.12% |
| 2021 Q2 | -446.97 Million CNY | -1344.14% |
| 2020 Q4 | 31 Million CNY | 0.0% |
| 2020 FY | 31 Million CNY | 207.29% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q2 | 24.92 Million CNY | -94.52% |
| 2020 Q1 | 454.71 Million CNY | 1673.37% |
| 2019 Q4 | -28.9 Million CNY | 0.0% |
| 2019 FY | -28.9 Million CNY | 66.48% |
| 2018 FY | -86.22 Million CNY | -561.64% |
| 2017 FY | -13.03 Million CNY | 0.0% |